Structural optimization of imidazothiazole derivatives affords a new promising series as B-Raf V600E inhibitors; synthesis, in vitro assay and in silico screening
- Authors
- Ammar, Usama M.; Abdel-Maksoud, Mohammed S.; Ali, Eslam M. H.; Mersal, Karim, I; Yoo, Kyung Ho; Oh, Chang-Hyun
- Issue Date
- 2020-07
- Publisher
- ACADEMIC PRESS INC ELSEVIER SCIENCE
- Citation
- BIOORGANIC CHEMISTRY, v.100
- Keywords
- BIOLOGICAL EVALUATION; MALIGNANT-MELANOMA; BRAF; MUTATIONS; ENCORAFENIB; VEMURAFENIB; GROWTH; AGENTS; KINASE; BIOLOGICAL EVALUATION; MALIGNANT-MELANOMA; BRAF; MUTATIONS; ENCORAFENIB; VEMURAFENIB; GROWTH; AGENTS; KINASE; anti cancer; B-Raf V600E; Imidazo[2,1-b]thiazole; In silico screening
- ISSN
- 0045-2068
- URI
- https://pubs.kist.re.kr/handle/201004/118430
- DOI
- 10.1016/j.bioorg.2020.103967
- Appears in Collections:
- KIST Article > 2020
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.